Immunovia Interim Report January-March 2022 presentation from April 28th, 2022, with Philipp Mathieu, Acting CEO & President and Karin Almqvist Liwendahl, Chief Financial Officer.
Weblink to telephone conference and presentation
Interim Report January-March 2022 Presentation (PDF format)
